Revenue
2018
2019
2020
2021
2022
2023
2024
2025
BIOCRYST PHARMACEUTICALS INC (BCRX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $874.8M | $450.7M | $331.4M | $270.8M | $157.2M | $17.8M | $48.8M | $20.7M | $25.2M | $26.4M | $48.3M | $13.6M | $17.3M | $26.3M | $19.6M | $62.4M | $74.6M |
| Research & development | $166.1M | $174.6M | $216.6M | $253.3M | $208.8M | $123.0M | $107.1M | $84.9M | $67.0M | $61.0M | $72.8M | $51.8M | $41.9M | $49.2M | $57.2M | $83.9M | $73.7M |
| Operating income | $341.0M | −$2.5M | −$103.7M | −$148.4M | −$177.7M | −$174.8M | −$99.5M | −$94.2M | −$57.4M | −$48.6M | −$39.4M | −$45.8M | −$30.7M | −$33.9M | −$49.6M | −$34.4M | −$13.7M |
| EBITDAderived | $342.4M | −$1.3M | −$102.1M | −$147.0M | −$176.9M | −$174.0M | −$98.7M | −$93.5M | −$56.7M | −$48.1M | −$39.3M | −$45.6M | −$30.4M | −$33.3M | −$48.7M | −$32.1M | — |
| Net income | $263.9M | −$88.9M | −$226.5M | −$247.1M | −$184.1M | −$182.8M | −$108.9M | −$101.3M | −$65.8M | −$55.1M | −$43.0M | −$45.2M | −$30.1M | −$39.1M | −$56.9M | −$33.9M | −$13.5M |
| Basic EPSper diluted share | $1.26 | -$0.43 | -$1.18 | -$1.33 | -$1.03 | -$1.09 | -$940.00 | -$0.98 | -$0.78 | -$0.75 | -$0.59 | -$0.68 | -$0.55 | -$0.79 | -$1.26 | -$0.76 | -$0.35 |
| Diluted EPSper diluted share | $1.21 | -$0.43 | -$1.18 | -$1.33 | -$1.03 | -$1.09 | -$940.00 | -$0.98 | -$0.78 | -$0.75 | -$0.59 | -$0.68 | -$0.55 | -$0.79 | -$1.26 | -$0.76 | -$0.35 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 18, 2026Form 4 | McKee Amy EDirector | SellCommon Stock | 11.2K | $8.97 | $100.3K | 31.3K |
| May 13, 2026Form 4 · 10b5-1 | Barnes Alane PChief Legal Officer | SellCommon Stock | 62.5K | $9.54 | $596.3K | 400.7K |
| Mar 20, 2026Form 4 | HEGGIE THERESADirector | SellCommon Stock | 49.9K | $10.11 | $504.8K | 65.4K |
| Mar 16, 2026Form 4 · 10b5-1 | Barnes Alane PChief Legal Officer | SellCommon Stock | 150.0K | $9.15 | $1.37M | 400.7K |
| Dec 22, 2025Form 4 · 10b5-1 | Barnes Alane PChief Legal Officer | SellCommon Stock | 21.8K | $7.65 | $166.6K | 398.8K |